Target intelligence / Profile preview

Lactose synthase complex (LS (occasionally used, but not universal))

Target
LS (occasionally used, but not universal)
Molecular classification
Enzyme Complex, Glycosyltransferase, Regulatory protein, C-type lysozyme/alpha-lactalbumin family, Glycosyltransferases
01

Overview

The **lactose synthase complex** is an enzymatic heterodimer found primarily in the mammary gland during lactation. It consists of two proteins: * **Beta-1,4-galactosyltransferase 1 (β4Gal-T1):** - A glycosyltransferase that normally transfers galactose from UDP-galactose to N-acetylglucosamine residues on glycoproteins. * **Alpha-lactalbumin (α-LA):** - A regulatory protein specific to the mammary gland that modifies β4Gal-T1’s substrate specificity from N-acetylglucosamine to glucose by promoting glucose binding at the active site[3][5]. Together they catalyze the final step in lactose biosynthesis: \[ \text{UDP-Gal} + \text{Glucose} \rightarrow \text{Lactose} + \text{UDP} \] This reaction produces *lactose*, which is the primary carbohydrate found in milk. The interaction between α-LA and β4Gal-T1 induces conformational changes necessary for efficient glucose binding and catalysis[3][5]. Structural studies have revealed how α-LA modulates substrate specificity through allosteric effects on β4Gal-T1’s active site region[3][5]. While both subunits are well-characterized biochemically and structurally—and each has its own UniProt entry—the functional unit “lactose synthase” refers specifically to their combined activity during lactation. This enzymatic activity has no current role as a drug target nor any established links with human disease outside rare congenital deficiencies affecting milk production[3][5].

Other names
Lactose synthetaseLSβ4Gal-T1/α-LA complexBeta-1,4-galactosyltransferase 1–alpha-lactalbumin complex
02

Mechanism of action

Not applicable—no drugs currently target this enzyme system.

03

Biological functions

Synthesis of lactose in mammary glandsModification of sugar acceptor specificity in galactosylation reactions
04

Disease associations

No direct disease association; however, defects in either component could theoretically affect milk production or composition.
05

Safety considerations

Not applicable—no safety concerns reported related to targeting this enzyme system therapeutically.
06

Interacting drugs

None known. No approved drugs directly interact with the lactose synthase complex or its components for therapeutic purposes.
07

Biomarkers

None established for clinical use. Neither component is used as a biomarker for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on Lactose synthase complex (LS (occasionally used, but not universal)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactose synthase complex (LS (occasionally used, but not universal)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call